Filomena De Luca

2.2k total citations
41 papers, 1.5k citations indexed

About

Filomena De Luca is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Filomena De Luca has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Medicine, 16 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Filomena De Luca's work include Antibiotic Resistance in Bacteria (32 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers) and Tuberculosis Research and Epidemiology (9 papers). Filomena De Luca is often cited by papers focused on Antibiotic Resistance in Bacteria (32 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers) and Tuberculosis Research and Epidemiology (9 papers). Filomena De Luca collaborates with scholars based in Italy, United States and France. Filomena De Luca's co-authors include Jean‐Denis Docquier, Manuela Benvenuti, Stefano Mangani, Gian María Rossolini, Sushmita D. Lahiri, Thomas F. Durand-Réville, Gautam Sanyal, Cecilia Pozzi, Maurizio Botta and C. Mugnaioli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Physical Chemistry B and Cancer Research.

In The Last Decade

Filomena De Luca

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Filomena De Luca Italy	20	1.1k	487	466	311	296	41	1.5k
Carine Bebrone Belgium	22	1.3k 1.2×	483 1.0×	641 1.4×	343 1.1×	280 0.9×	30	1.9k
Sarah M. Drawz United States	17	1.6k 1.5×	844 1.7×	618 1.3×	456 1.5×	308 1.0×	24	2.2k
Sushmita D. Lahiri United States	28	1.1k 1.0×	700 1.4×	1.0k 2.2×	371 1.2×	202 0.7×	41	2.3k
R.A. Powers United States	19	854 0.8×	461 0.9×	395 0.8×	229 0.7×	177 0.6×	33	1.1k
Beibei Liang China	20	800 0.7×	243 0.5×	619 1.3×	223 0.7×	389 1.3×	59	1.7k
Michiyoshi Nukaga Japan	18	893 0.8×	407 0.8×	398 0.9×	237 0.8×	207 0.7×	38	1.2k
Dustin T. King Canada	19	952 0.9×	454 0.9×	777 1.7×	277 0.9×	103 0.3×	32	1.7k
David E. Ehmann United States	22	1.1k 1.0×	1.0k 2.1×	994 2.1×	334 1.1×	158 0.5×	29	2.2k
Leticia I. Llarrull United States	25	1.0k 0.9×	453 0.9×	758 1.6×	300 1.0×	141 0.5×	35	1.9k
Haris Jahić United States	10	810 0.7×	503 1.0×	295 0.6×	262 0.8×	111 0.4×	13	994

Countries citing papers authored by Filomena De Luca

Since Specialization

Citations

This map shows the geographic impact of Filomena De Luca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filomena De Luca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filomena De Luca more than expected).

Fields of papers citing papers by Filomena De Luca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filomena De Luca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filomena De Luca. The network helps show where Filomena De Luca may publish in the future.

Co-authorship network of co-authors of Filomena De Luca

This figure shows the co-authorship network connecting the top 25 collaborators of Filomena De Luca. A scholar is included among the top collaborators of Filomena De Luca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filomena De Luca. Filomena De Luca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gavara, Laurent, Lionel Nauton, Paola Sandra Mercuri, et al.. (2022). 1,2,4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors. Bioorganic & Medicinal Chemistry. 72. 116964–116964. 5 indexed citations

Gavara, Laurent, Lionel Nauton, Paola Sandra Mercuri, et al.. (2021). 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors. Bioorganic Chemistry. 113. 105024–105024. 12 indexed citations

Piccirilli, Alessandra, Fabrizia Brisdelli, Jean‐Denis Docquier, et al.. (2020). Amino Acid Replacement at Position 228 Induces Fluctuation in the Ω-Loop of KPC-3 and Reduces the Affinity against Oxyimino Cephalosporins: Kinetic and Molecular Dynamics Studies. Catalysts. 10(12). 1474–1474. 2 indexed citations

Spyrakis, Francesca, Matteo Santucci, Lorenzo Maso, et al.. (2020). Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases. Scientific Reports. 10(1). 12763–12763. 27 indexed citations

Liu, Bin, Robert E. Lee Trout, Guo‐Hua Chu, et al.. (2019). Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. Journal of Medicinal Chemistry. 63(6). 2789–2801. 219 indexed citations

Everett, Martin, Alicia Coelho, Jérôme Castandet, et al.. (2018). Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 62(5). 84 indexed citations

Zamperini, Claudio, Davide Deodato, Chris Pasero, et al.. (2017). Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents. Scientific Reports. 7(1). 8251–8251. 29 indexed citations

Deodato, Davide, et al.. (2017). Design and synthesis of a novel inhibitor of T. Viride chitinase through an in silico target fishing protocol. Bioorganic & Medicinal Chemistry Letters. 27(15). 3332–3336. 10 indexed citations

Pisa, F. Di, Cecilia Pozzi, Manuela Benvenuti, et al.. (2017). Boric acid and acetate anion binding to subclass B3 metallo-β-lactamase BJP-1 provides clues for mechanism of action and inhibitor design. Inorganica Chimica Acta. 470. 331–341. 5 indexed citations

10.

Santucci, Matteo, Francesca Spyrakis, Simon Cross, et al.. (2017). Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases. Scientific Reports. 7(1). 17716–17716. 32 indexed citations

11.

Luca, Filomena De, et al.. (2014). Occurrence of conjugative IncF-type plasmids harboring the blaCTX-M-15 gene in Enterobacteriaceae isolates from newborns in Tunisia. Pediatric Research. 77(1). 107–110. 12 indexed citations

12.

Luca, Filomena De, Davide Deodato, Claudio Zamperini, et al.. (2014). Synthesis of linear and cyclic guazatine derivatives endowed with antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 24(23). 5525–5529. 15 indexed citations

13.

Lahiri, Sushmita D., Stefano Mangani, Haris Jahić, et al.. (2014). Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48. ACS Chemical Biology. 10(2). 591–600. 90 indexed citations

14.

Camerini, Andrea, Sara Donati, Paolo Viacava, et al.. (2011). Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. Journal of Experimental & Clinical Cancer Research. 30(1). 38–38. 13 indexed citations

15.

Luca, Filomena De, Manuela Benvenuti, Filippo Carboni, et al.. (2011). Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D β-lactamase OXA-10 by rational protein design. Proceedings of the National Academy of Sciences. 108(45). 18424–18429. 57 indexed citations

16.

Sgambato, Alessandro, Andrea Camerini, Giannicola Genovese, et al.. (2010). Loss of nuclear p27^kip1 and α‐dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Science. 101(9). 2080–2086. 21 indexed citations

17.

Poirel, Laurent, et al.. (2009). BEL-2, an Extended-Spectrum β-Lactamase with Increased Activity toward Expanded-Spectrum Cephalosporins in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 54(1). 533–535. 22 indexed citations

18.

Docquier, Jean‐Denis, V. Calderone, Filomena De Luca, et al.. (2009). Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases. Chemistry & Biology. 16(5). 540–547. 138 indexed citations

19.

Sgambato, Alessandro, Andrea Camerini, D. Amoroso, et al.. (2007). Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma. Cancer Biology & Therapy. 6(12). 1840–1846. 29 indexed citations

20.

Campani, Daniela, R Sarnelli, Gabriella Fontanini, et al.. (1993). Receptor Status, Proliferating Activity, and c‐erbB2 Oncoprotein. Annals of the New York Academy of Sciences. 698(1). 167–173. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact